http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2015193706-A1
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2213d6fa6b8514a3bae8fcd16734f625 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2267-0312 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01K2227-10 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K49-0008 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K49-00 |
filingDate | 2014-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dc8493467e8101ceb076e9168cd557fa http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7f61db8d1b5562afc460e7bdf1c72059 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e8f78a785cd62e6b18c7d8c367f8ef24 |
publicationDate | 2015-12-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | WO-2015193706-A1 |
titleOfInvention | Method for alzheimer's disease drug screening and biomarker evaluation |
abstract | Octogon degus are the only rodents known to spontaneously develop an Alzheimer's disease (AD)-like neuropathology with hallmark pathological markers, such as amyloid-β (Αβ) plaques and tau hyperphosphorylation, and a concomitant age-related decline in cognition. Nevertheless, it is difficult to discriminate between healthy animals, and those developing the AD-like disease. The present invention is directed to identify individuals that will likely develop AD-like neuropathology. Also, the invention considers a method for drug screening of potentially beneficial compounds, and a method for identification of AD biomarkers. |
priorityDate | 2014-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 21.